Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: back pain

High-Intensity Strength Training May Not Improve OA Knee Pain

Lara C. Pullen, PhD  |  March 17, 2021

High-intensity strength training may be no more beneficial than low-intensity strength training at improving pain and joint compression in patients with knee osteoarthritis, according to a recent study.

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:Exerciseexercise therapyKnee Osteoarthritis (OA)knee pain

Chikungunya Virus May Lead to Long-Term Joint Pain

Linda Childers  |  November 18, 2020

COVID-19 isn’t the only viral infection on the rise across the globe, so is chikungunya, which can cause arthritis-like symptoms and may lead to long-term joint pain.

Filed under:ConditionsPain Syndromes Tagged with:arthritis painchikungunyaCHIKVChronic painJoint Pain

Motortion Films / shutterstock.com

A Look Back at Pirquet & Schick’s Influential Serum Sickness Study

Ruth Jessen Hickman, MD  |  November 12, 2020

In 1905, two pediatricians in Vienna, Austria, published Serum Sickness, a detailed 120-page monograph that was the first to carefully characterize the syndrome.1 The work would go on to become a classic, ultimately helping illuminate many important questions in immunology. Antitoxin Serum Treatments In the late 19th century, researchers were working to develop lifesaving antitoxins…

Filed under:Conditions Tagged with:Lost & FoundSerum Sickness

Hand Pain Depends on More Than Osteoarthritis Severity & Psych Profile

Thomas R. Collins  |  October 19, 2020

Pain is the main reason patients with osteoarthritis (OA) seek medical help because of the substantial burden it imposes and its impact on quality of life. Pain can actually change the way the central nervous system works. This central sensitization results in more pain with less provocation. And according to results from an observational study…

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:arthritis painhand painPain Management

Nerve Growth Factor Inhibitor Study Highlights Promise as an OA Pain Treatment

Ruth Jessen Hickman, MD  |  October 1, 2020

A study highlights the potential of fasinumab, an anti-nerve growth factor monoclonal antibody, as a pain treatment for osteoarthritis (OA) patients. Research into the risks and benefits of this therapeutic class for OA are ongoing…

Filed under:Drug UpdatesOsteoarthritis and Bone DisordersResearch Rheum Tagged with:Arthritis & RheumatologyfasinumabKnee Osteoarthritis (OA)Nerve growth factor (NGF)osteoarthritis (OA)tanezumab

A transverse view of the ulnar groove in full elbow extension. The red arrow indicates the advancing edge of the MHTr.

Recurrent Medial Elbow Pain Following Successful Tommy John Surgery

Mark H. Greenberg, MD, RMSK, RhMSUS, A. Lee Day, MD, RMSK, James W. Fant Jr., MD, & Christopher G. Mazoue, MD  |  August 12, 2020

A 27-year-old, left-handed man was referred to our ultrasound clinic for left elbow pain. History The patient had been a pitcher on a Minor League Baseball team. Two years before, he developed sudden, severe medial elbow pain while pitching in a game. The pain was associated with some tingling down the left medial forearm. The…

Filed under:Conditions Tagged with:case reportdiagnostic imagingelbow painTommy John Surgeryulnar nerveulnar nerve instabilityulnar nerve relocation syndromeultrasonographyUltrasound

Ixekizumab May Improve Pain & Sexual Health in Patients with Genital Psoriasis

Michele B. Kaufman, PharmD, BCGP  |  July 14, 2020

Research has shown ixekizumab improves pain and the sexual health of patients with genital psoriasis…

Filed under:Drug Updates Tagged with:genital psoriasisixekizumabPsoriasissexual health

Lemau Studio / shutterstock.com

Tips for Understanding the Pathways of Pain & Choosing Treatments

Carina Stanton  |  May 15, 2020

SNOWMASS VILLAGE, COLO.—The science underlying the neurobiology of chronic pain isn’t something rheumatologists often think about. However, pain is an important reason why patients see a rheumatologist. At the 2020 ACR Winter Symposium in January, Leslie Crofford, MD, gave two presentations addressing pain experienced by rheumatology patients, including a session on the fundamental mechanisms of…

Filed under:AnalgesicsConditions Tagged with:Pain Managementpain mechanismspain pathwaysWinter Rheumatology Summit

FDA Considers Tanezumab Application for Chronic OA Pain

Michele B. Kaufman, PharmD, BCGP  |  April 20, 2020

The FDA is considering an application for subcutaneous tanezumab, a monoclonal antibody, as a treatment for moderate to severe osteoarthritis…

Filed under:AnalgesicsConditionsDrug UpdatesPain Syndromes Tagged with:Chronic painFDAosteoarthritis (OA)PainPain ManagementtanezumabU.S. Food and Drug Administration (FDA)

Right: The same view as 2A, with the common peroneal nerve outlined in yellow with a cross-sectional area of 21 mm2.

Case Report: Ultrasound Reveals Cause of Post-Arthroplasty Knee Pain

Mark H. Greenberg, MD, RMSK, RhMSUS, Elijah Mitcham, MD, Prem Patel, James W. Fant Jr., MD, & Frank R. Voss, MD  |  April 15, 2020

A 65-year-old woman was referred by an orthopedist to a rheumatologist for left knee pain. Previously, in 2014, she underwent left total knee arthroplasty (TKA) for severe osteoarthritis in a different institution. Following the procedure, she experienced severe chronic anterolateral knee pain at rest, exacerbated by walking. Because she was rendered wheelchair bound and required…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:case reportcommon peroneal nervediagnostic imagingtotal knee arthroplastyUltrasound

  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 162
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences